Streetbeat News

Price Targets

VC

Wells Fargo analyst Colin Langan maintains an Underweight rating on Visteon (NASDAQ:VC) and raises the price target from $127 to $130.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 3:35 pm

LEA

Wells Fargo analyst Colin Langan has maintained an Equal-Weight rating on Lear Corporation (NYSE:LEA) and raised the price target from $141 to $144.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 3:35 pm

GM

Wells Fargo analyst Colin Langan has maintained an 'Underweight' rating on General Motors (NYSE:GM) and raised the price target from $30 to $32.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 3:33 pm

F

Wells Fargo analyst Colin Langan has maintained an 'Underweight' rating on Ford Motor (NYSE:F) and raised the price target from $10 to $11.

Portfolio Pulse from richadhand@benzinga.com

July 10, 2023 | 3:33 pm

PRTK

HC Wainwright & Co. analyst Ed Arce has reiterated a Neutral rating on Paratek Pharmaceuticals (NASDAQ:PRTK) and maintained a price target of $2.15.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:22 pm

IOVA

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Iovance Biotherapeutics (NASDAQ:IOVA) and maintained a price target of $38.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:21 pm

PBLA

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Panbela Therapeutics (NASDAQ:PBLA) and maintained a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:20 pm

ATAI

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on ATAI Life Sciences (NASDAQ:ATAI) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:18 pm

BWMX

Small Cap Consumer Research analyst Eric Beder has reiterated a 'Buy' rating on Betterware de Mexico SAPI (NASDAQ:BWMX) and raised the price target from $15 to $17.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:17 pm

FMC

Fermium Research analyst Frank Mitsch has maintained a 'Hold' rating on FMC (NYSE:FMC) and lowered the price target from $125 to $105.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:14 pm